Dense breast tissue makes breast screening more challenging because the accuracy of mammograms is diminished in dense tissue.  SureTouch overcomes the density challenge and is accurate in women with dense breasts because it measures tissue hardness or elasticity, rather than density.  

Women with fibrocystic breasts often have lumpy breast tissue that makes it hard to identify lumps that are significant.  Fibrocystic and glandular tissue can be soft or hard depending on the hormonal cycle. SureTouch determines the hardness of tissue and compares it with surrounding tissue, and identifies masses that are abnormal and not part of the fibrocystic lumpiness.  Sometimes patients with hard, lumpy tissue have a SureTouch exam and are asked to return in two weeks for a second exam; a second exam will allows SureTouch to identify lumps that are the result of hormonal changes, and masses that require a diagnostic test.

The incidence of breast cancer in young women is increasing.

Today, 1 in 229 women under the age of 40 are at risk for developing breast cancer, and increasingly younger women are seeking screening.

The American Cancer Society recommends that women do not have mammograms before the age of 40. This is because radiation exposure to women at an early age is dangerous – it’s been shown to increase the risk of breast cancer – and mammograms a very inaccurate with the dense breasts of younger women. 

In 2017, 10% of all breast cancers will be diagnosed in women under the age of 45. This means that this year 20,000 young women under the age of 45 will be diagnosed with breast cancer, before they ever had a chance at early detection of their cancers. 

SureTouch is a great screening exam for younger women.  SureTouch is accurate in young women, has no radiation danger, and is painless and easy, and can begin a lifetime and lifesaving habit of regular screening and self-protection.